X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (73942) 73942
Book Review (11254) 11254
Publication (5602) 5602
Newsletter (2054) 2054
Newspaper Article (444) 444
Book Chapter (440) 440
Conference Proceeding (264) 264
Magazine Article (100) 100
Dissertation (66) 66
Transcript (61) 61
Book / eBook (45) 45
Reference (25) 25
Trade Publication Article (19) 19
Paper (7) 7
Web Resource (7) 7
Data Set (3) 3
Journal / eJournal (3) 3
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (59096) 59096
humans (57332) 57332
male (26164) 26164
female (25459) 25459
middle aged (20020) 20020
oncology (17741) 17741
aged (17331) 17331
adult (15708) 15708
hematology (14930) 14930
animals (12122) 12122
b-cell lymphoma (11003) 11003
lymphomas (10753) 10753
lymphoma (9969) 9969
cancer (9630) 9630
b cells (8203) 8203
mice (7846) 7846
abridged index medicus (7529) 7529
prognosis (7478) 7478
lymphoma, large b-cell, diffuse - pathology (7128) 7128
immunology (7009) 7009
aged, 80 and over (6810) 6810
expression (6669) 6669
rituximab (6414) 6414
non-hodgkins-lymphoma (6187) 6187
lymphoma, b-cell - pathology (6163) 6163
pathology (6156) 6156
research (5724) 5724
antineoplastic combined chemotherapy protocols - therapeutic use (5648) 5648
chemotherapy (5631) 5631
adolescent (5524) 5524
apoptosis (5441) 5441
treatment outcome (5252) 5252
leukemia (4964) 4964
immunohistochemistry (4669) 4669
lymphoma, large b-cell, diffuse - drug therapy (4431) 4431
b-cells (4230) 4230
child (4171) 4171
care and treatment (4136) 4136
lymphocytes b (4107) 4107
analysis (4022) 4022
diagnosis, differential (3918) 3918
b-lymphocytes - immunology (3884) 3884
hemic and lymphatic diseases (3843) 3843
gene expression (3840) 3840
chronic lymphocytic-leukemia (3828) 3828
health aspects (3826) 3826
cell biology (3809) 3809
survival (3740) 3740
genetic aspects (3609) 3609
diagnosis (3530) 3530
lymphocytes (3506) 3506
flow cytometry (3502) 3502
therapy (3485) 3485
lymphoma, large b-cell, diffuse - diagnosis (3411) 3411
proteins (3411) 3411
retrospective studies (3400) 3400
disease (3313) 3313
cell line, tumor (3292) 3292
antineoplastic agents - therapeutic use (3221) 3221
leukemia, lymphocytic, chronic, b-cell - pathology (3215) 3215
lymphoma, b-cell - genetics (3125) 3125
tumors (3033) 3033
diffuse large b-cell lymphoma (2979) 2979
article (2905) 2905
tumor cells, cultured (2902) 2902
mutation (2893) 2893
activation (2888) 2888
immunophenotyping (2858) 2858
chronic lymphocytic leukemia (2831) 2831
t cells (2806) 2806
medicine, research & experimental (2797) 2797
biopsy (2782) 2782
lymphoma, b-cell - drug therapy (2780) 2780
biochemistry & molecular biology (2768) 2768
non-hodgkin's lymphomas (2704) 2704
lymphoma, large b-cell, diffuse - genetics (2651) 2651
young adult (2623) 2623
leukemia, lymphocytic, chronic, b-cell - drug therapy (2597) 2597
medicine & public health (2566) 2566
signal transduction (2563) 2563
polymerase chain reaction (2551) 2551
neoplasm staging (2549) 2549
b-cell (2539) 2539
lymphoma, b-cell - diagnosis (2525) 2525
risk factors (2508) 2508
follicular lymphoma (2501) 2501
leukemia, lymphocytic, chronic, b-cell - genetics (2487) 2487
immunotherapy (2482) 2482
lymphoma, b-cell - immunology (2468) 2468
child, preschool (2467) 2467
lymphoma, b-cell, marginal zone - pathology (2456) 2456
gene (2316) 2316
follow-up studies (2311) 2311
antibodies, monoclonal - therapeutic use (2310) 2310
genes (2302) 2302
neoplasms (2270) 2270
b-lymphocytes - metabolism (2269) 2269
lymphoma, non-hodgkin - pathology (2261) 2261
classification (2245) 2245
molecular sequence data (2184) 2184
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (68827) 68827
German (1438) 1438
Japanese (1377) 1377
French (1371) 1371
Chinese (986) 986
Spanish (698) 698
Italian (673) 673
Russian (650) 650
Polish (243) 243
Korean (235) 235
Hungarian (89) 89
Czech (87) 87
Portuguese (77) 77
Danish (55) 55
Romanian (55) 55
Dutch (53) 53
Turkish (42) 42
Serbian (28) 28
Croatian (23) 23
Swedish (19) 19
Bulgarian (18) 18
Norwegian (17) 17
Slovak (17) 17
Hebrew (16) 16
Finnish (13) 13
Ukrainian (6) 6
Persian (4) 4
Lithuanian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Galician (1) 1
Greek (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 1, pp. 49 - 58
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL), are rare neoplasms characterized by highly... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | SURGERY | MALIGNANT-LYMPHOMAS | TRANSLOCATIONS | T(14/18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | POOR-PROGNOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 6, pp. 806 - 810
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
To the authors' knowledge, the current study is the first large comparative analysis of double‐hit lymphomas by patterns of oncogene rearrangement. Patterns of... 
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | TRANSLOCATIONS | IN-VIVO EFFICACY | DOXORUBICIN | B-CELL LYMPHOMA | PREDNISONE | BCL6 | ONCOLOGY | VINCRISTINE | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission. We... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article